{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:57:26Z","timestamp":1760623046999,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12890-017-0474-7","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T22:22:29Z","timestamp":1512166949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["An implantable pump Lenus pro\u00ae in the treatment of pulmonary arterial hypertension with intravenous treprostinil"],"prefix":"10.1186","volume":"17","author":[{"given":"Marcin","family":"Kurzyna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9049-546X","authenticated-orcid":false,"given":"Katarzyna","family":"Ma\u0142aczy\u0144ska-Rajpold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Koteja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Chrzanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Furdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Jache\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"Sobkowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Norwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Mularek-Kubzdela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,2]]},"reference":[{"key":"474_CR1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","volume":"165","author":"G Simonneau","year":"2002","unstructured":"Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:800\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"474_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1378\/chest.129.6.1636","volume":"129","author":"I Lang","year":"2006","unstructured":"Lang I, Gomez-Sanchez M, Kneussl M, Naeije R, Escribano P, Skoro-Sajer N, et al. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest. 2006;129:1636\u201343. doi: 10.1378\/chest.129.6.1636 .","journal-title":"Chest"},{"key":"474_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37:67\u2013119.","journal-title":"Eur Heart J"},{"key":"474_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00005344-200302000-00019","volume":"41","author":"VV McLaughlin","year":"2003","unstructured":"McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, et al. Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol. 2003;41:293\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"key":"474_CR5","unstructured":"Xu QA, Trissel LA, Pham L. Physical and chemical stability of Treprostinil sodium injection packaged in plastic syringe pump reservoirs. Int J Pharm Compd. 8:228\u201330."},{"key":"474_CR6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/0091270004264638","volume":"44","author":"M Wade","year":"2004","unstructured":"Wade M, Baker FJ, Roscigno R, DellaMaestra W, Arneson CP, Hunt TL, et al. Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion. J Clin Pharmacol. 2004;44:503\u20139.","journal-title":"J Clin Pharmacol"},{"key":"474_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.healun.2012.02.025","volume":"31","author":"R Sadushi-Koli\u00e7i","year":"2012","unstructured":"Sadushi-Koli\u00e7i R, Skoro-Sajer N, Zimmer D, Bonderman D, Schemper M, Klepetko W, et al. Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension. J Heart Lung Transplant. 2012;31:735\u201343. doi: 10.1016\/j.healun.2012.02.025 .","journal-title":"J Heart Lung Transplant"},{"key":"474_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.112.124388","volume":"127","author":"Z-C Jing","year":"2013","unstructured":"Jing Z-C, Parikh K, Pulido T, Jerjes-Sanchez C, White RJ, Allen R, et al. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial. Circulation. 2013;127:624\u201333. doi: 10.1161\/CIRCULATIONAHA.112.124388 .","journal-title":"Circulation"},{"key":"474_CR9","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1586\/14779072.2014.975209","volume":"12","author":"N Skoro-Sajer","year":"2014","unstructured":"Skoro-Sajer N, Lang I. Extended-release oral treprostinil for the treatment of pulmonary arterial hypertension. Expert Rev Cardiovasc Ther. 2014;12:1391\u20139. doi: 10.1586\/14779072.2014.975209 .","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"474_CR10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1517\/17425255.2014.958466","volume":"10","author":"JL Hellawell","year":"2014","unstructured":"Hellawell JL, Bhattacharya S, Farber HW. Pharmacokinetic evaluation of treprostinil (oral) for the treatment of pulmonary arterial hypertension. Expert Opin Drug Metab Toxicol. 2014;10:1445\u201353. doi: 10.1517\/17425255.2014.958466 .","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"474_CR11","first-page":"1","volume":"9","author":"SC Pugliese","year":"2016","unstructured":"Pugliese SC, Bull TM. Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension. Integr Blood Press Control. 2016;9:1\u20137.","journal-title":"Integr Blood Press Control"},{"key":"474_CR12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/682224","volume":"5","author":"KM Chin","year":"2015","unstructured":"Chin KM, Ruggiero R, Bartolome S, Velez-Martinez M, Darsaklis K, Kingman M, et al. Long-term therapy with oral treprostinil in pulmonary arterial hypertension failed to lead to improvement in important physiologic measures: results from a single center. Pulm Circ. 2015;5:513\u201320.","journal-title":"Pulm Circ"},{"key":"474_CR13","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.2165\/11638260-000000000-00000","volume":"72","author":"N Skoro-Sajer","year":"2012","unstructured":"Skoro-Sajer N. Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulations. Drugs. 2012;72:2351\u201363. doi: 10.2165\/11638260-000000000-00000 .","journal-title":"Drugs"},{"key":"474_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/0091270003261343","volume":"44","author":"M Wade","year":"2004","unstructured":"Wade M, Baker FJ, Roscigno R, DellaMaestra W, Hunt TL, Lai AA. Absolute bioavailability and pharmacokinetics of treprostinil sodium administered by acute subcutaneous infusion. J Clin Pharmacol. 2004;44:83\u20138.","journal-title":"J Clin Pharmacol"},{"key":"474_CR15","doi-asserted-by":"crossref","first-page":"904A","DOI":"10.1378\/chest.1118323","volume":"140","author":"R Steringer-Mascherbauer","year":"2011","unstructured":"Steringer-Mascherbauer R, Eder V, Ebner C, Niel J, Fuegger R, Wittrich S, et al. First experiences with intravenous Treprostinil delivered by an implantable pump (Lenus pro\u00ae) with filling intervals of 28 days in patients with pulmonary arterial hypertension (PAH) - a series of five cases. CHEST J. 2011;140:904A.","journal-title":"CHEST J"},{"key":"474_CR16","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.healun.2013.01.974","volume":"37","author":"R Steringer-Mascherbauer","year":"2013","unstructured":"Steringer-Mascherbauer R, Eder V, Huber C, Wittrich S, Marecek I, Nesser HJ. Intravenous treprostinil delivered by the implantable pump Lenus pro\u00ae: a innovative \u201csurgical\u201d approach to management of PAH. J Hear Lung Transplant. 2013;37:S64.","journal-title":"J Hear Lung Transplant"},{"key":"474_CR17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.hrtlng.2012.07.001","volume":"41","author":"S Desole","year":"2012","unstructured":"Desole S, Velik-Salchner C, Fraedrich G, Ewert R, K\u00e4hler CM. Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension. Heart Lung. 2012;41:599\u2013605.","journal-title":"Heart Lung"},{"key":"474_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5603\/KP.2016.0030.","volume":"74","author":"A Pawlak","year":"2016","unstructured":"Pawlak A, Koteja A, Starska A, Kurzyna M, Gil RJ. The first LENUS pro\u00ae pump implantation in Poland in patient with pulmonary hypertension. Kardiol Pol. 2016;74:300. doi: 10.5603\/KP.2016.0030.","journal-title":"Kardiol Pol"},{"key":"474_CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chest.2015.11.005","volume":"150","author":"RC Bourge","year":"2016","unstructured":"Bourge RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, Tarver JH, Zwicke DL, et al. Treprostinil administered to treat pulmonary artery hypertension using a fully implantable programmable intravascular delivery system: results of the DelIVery for PAH trial. Chest. 2016;150:27\u201334.","journal-title":"Chest"},{"key":"474_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"474_CR21","first-page":"1166","volume":"67","author":"J Tylka","year":"2009","unstructured":"Tylka J, Piotrowicz R. Quality of life assessment questionnaire (SF-36) - polish version. Kardiol Pol. 2009;67:1166\u20139.","journal-title":"Kardiol Pol"},{"key":"474_CR22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5603\/CJ.2016.0076","volume":"23","author":"K Malaczynska-Rajpold","year":"2016","unstructured":"Malaczynska-Rajpold K, Kurzyna M, Koteja A, Torbicki A, Mularek-Kubzdela T. The \u201cbouncing\u201d catheter. Cardiol J. 2016;23:552\u20133.","journal-title":"Cardiol J"},{"key":"474_CR23","doi-asserted-by":"crossref","unstructured":"Richter MJ, Ewert R, Warnke C, Gall H, Classen S, Grimminger F, et al. Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension. Clin Res Cardiol. 2016:1\u20139.","DOI":"10.1007\/s00392-016-1037-2"},{"key":"474_CR24","unstructured":"B\u00fclow M, Otto K-H. Tricumed. Urgent Safety Information 2013. https:\/\/www.swissmedic.ch\/recalllists_dl\/08938\/Vk_20131223_02-e1.pdf ."},{"key":"474_CR25","first-page":"161","volume":"7","author":"W Hohenforst-Schmidt","year":"2013","unstructured":"Hohenforst-Schmidt W, Hornig J, Friedel N, Zarogoulidis P, Zarogoulidis K, Brachmann J. Successful management of an inadvertent excessive treprostinil overdose. Drug Des Devel Ther. 2013;7:161\u20135.","journal-title":"Drug Des Devel Ther"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-017-0474-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T04:26:11Z","timestamp":1570422371000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-017-0474-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1186\/s12890-017-0474-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"type":"electronic","value":"1471-2466"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"162"}}